Researchers analysed data from 831 women and 651 male partners in a prospective study in the Netherlands.

Diet was assessed during early pregnancy, and ultra-processed food intake was measured as a share of total daily food intake.

The researchers then looked at time to pregnancy, subfertility and markers of early embryonic development.

In men, higher intake of ultra-processed foods was linked to a greater risk of subfertility and a longer time to conception.

In women, the picture was slightly different.

Higher intake was not consistently linked to subfertility or time to pregnancy, but it was associated with slightly smaller embryonic growth and a smaller yolk sac by the seventh week of pregnancy.

These differences were small, but they matter because early embryonic growth can be linked to later pregnancy outcomes.

The study cannot tell us exactly why these associations were seen.

It may be related to poor nutritional quality, food additives, packaging chemicals or other features of ultra-processed diets.

The researchers also make an important broader point.

Fertility and early pregnancy are not just about the mother’s health.

• Ultra-processed foods in preschool years associated with behavioural difficulties
• Ultra processed foods are engineered like cigarettes
• Ultra-processed foods engineered to be addictive

The father’s diet and health status may matter as well.

That is something preconception advice has often overlooked.

If you want, I can keep going in exactly this format for the next batch.

Researchers enrolled 90 healthy older adults and split them into three groups.

One group received no intervention.

One group received placebo pills but was told they contained active ingredients.

The third group was openly told the pills were inert, but that placebos can still trigger helpful mind-body responses.

After three weeks, both placebo groups showed improvements in some physical and cognitive measures.

• Keeping Active with Diabetes

The open-label placebo group, where people knew the pills were fake, showed particularly strong effects.

That group also reported lower perceived stress than the others.

Short-term memory improved significantly in the open-label placebo group compared with the control group.

The study is interesting because it suggests expectation, attention and self-perception may influence aspects of ageing more than people assume.

But it needs to be kept in proportion.

• Weight loss injection adverts from CheqUp, MedExpress and WLO pulled after regulator steps in
• Forget 10,000 steps: for older women, 4,000 is enough
• 5 steps to improve your cardiovascular health

This was a small study in healthy older adults over just three weeks.

It does not mean placebo pills are a magic answer for memory loss, frailty or age-related decline.

What it does show is that the mind can influence outcomes in measurable ways, even when people are fully aware they are taking an inactive pill.

Microwave ovens work by using electromagnetic waves that excite water and charged molecules in food.

That creates heat quickly inside the food.

The key point is that nutrient loss is not mainly about the microwave itself.

It is about how much heat is used, how long the food is cooked and how much water is involved.

That is why boiling can sometimes be worse for vitamins than microwaving.

Water-soluble vitamins such as vitamin C can leach into cooking water, especially when vegetables are boiled for too long.

Microwaving often uses less water and shorter cooking times, which can help reduce that loss.

That does not mean microwaving is perfect.

Heat-sensitive nutrients can still be affected, and different foods respond differently.

Proteins, starches and fats also change during microwaving, but that happens with other cooking methods too.

Another common myth is that microwaves make food radioactive.

They do not.

Microwave ovens use non-ionising radiation, which heats food but does not change it into something radioactive.

• Microwave innovation prevents double amputation for one patient
• Nutrition led rehab scheme aims to support recovery from alcohol dependence
• Impact of bananas on nutrient absorption highlights important role of food combinations

The main practical issue with microwaves is uneven heating.

That is more of a food safety concern than a nutrition problem, especially when reheating leftovers.

Overall, the science is fairly clear.

Microwaving is not uniquely harmful and, used properly, can be a sensible way to cook food while preserving nutrients.

Researchers followed 10,978 adults aged 65 and over for six years.

They looked at how often people cooked meals from scratch at home and how skilled they were in the kitchen.

Cases of dementia were identified through the public insurance system.

During follow-up, 1,195 people developed dementia.

People who cooked from scratch at least once a week had a lower risk than those who cooked less than once a week.

The reduction was 23% in men and 27% in women.

Among people with lower cooking skills, cooking at least once a week was linked to a 67% lower risk.

That does not necessarily mean cooking is protective in itself.

But it may reflect a mix of physical activity, planning, memory, sequencing and general day-to-day engagement.

In other words, cooking is not just about food.

• Cooking lessons in schools an important contribution to children’s healthy eating as they grow up
• Essential Diabetes Cookbook

It can also be a mentally and physically active task.

The researchers adjusted for factors such as education, income and other activities linked to cognitive reserve.

Even so, this is still an observational study, and the findings may not translate neatly across different cultures and lifestyles.

Still, it is a useful reminder that everyday routines can matter for brain health.

Researchers looked at 120 adults with overweight or obesity who had been treated with tirzepatide for at least 12 months.

They compared postmenopausal women who were also using hormone therapy with those who were not.

Women using both treatments lost significantly more weight on average.

The difference was around 35%, which is large enough to get attention.

• GLP-1 medicines: side effects, rare risks and what to monitor
• Weight loss surgery outperforms GLP-1 drugs in real-world use

There are a few possible explanations.

It may be that oestrogen enhances the appetite-suppressing effects of GLP-1 based medicines.

It is also possible that women using hormone therapy were already feeling better, sleeping better or staying more engaged with lifestyle changes.

That is why the study needs to be interpreted carefully.

Because this was not a randomised trial, it cannot show that hormone therapy directly caused the extra weight loss.

It also does not mean hormone therapy should be started purely as a weight loss add-on.

Hormone therapy has its own risks, benefits and suitability criteria.

• • GLP-1 weight loss drugs linked to small rise in chronic cough
  • Most weight lost on GLP-1 drugs returns within a year after stopping

Still, the study is interesting because it points towards a more personalised approach to obesity treatment in postmenopausal women.

It suggests menopause status and hormone treatment may matter more than many clinicians have assumed.

Metformin has been used for more than 60 years, but scientists still have not fully pinned down how it works.

Most of the focus has been on the liver and, more recently, the gut.

This new study points to the brain as another important part of the story.

Researchers looked at a protein called Rap1 in a brain region known as the ventromedial hypothalamus.

In diabetic mice, metformin’s blood sugar-lowering effect at clinically relevant doses depended on suppressing Rap1 activity in that area.

When mice lacked Rap1 in this region, low-dose metformin no longer improved blood sugar.

Other diabetes treatments, including insulin and GLP-1 drugs, still worked.

That suggests the effect was specific to metformin rather than a general failure to respond to treatment.

The team also gave tiny amounts of metformin directly into the brain.

Even at doses far lower than those taken by mouth, blood sugar still fell.

They then identified a group of neurons called SF1 neurons as part of the pathway.

• Metformin may reduce long COVID risk when taken early in infection
• Metformin may work in the brain as well as the liver and gut
• Skin cancer risk lowered by metformin

This is a fascinating mechanistic study, but it is still a mouse study.

It does not mean metformin should suddenly be thought of as a brain drug in routine diabetes care.

What it does mean is that one of the world’s most familiar diabetes medicines may be working in a more complex way than we realised.

Researchers at Stanford continuously tracked 81 African turquoise killifish throughout adult life.

Even though the fish were genetically similar and lived in the same conditions, they aged very differently.

By early mid-life, those differences were already showing up in how they moved and rested.

Fish that later lived longer were generally more active during the day and swam with more vigour.

Fish that later died earlier were more likely to become less active and to sleep more during the day.

The researchers found these behaviour patterns were strong enough to predict lifespan.

They also found that ageing did not unfold as a slow, steady slide.

Instead, the fish tended to stay stable for a while, then shift quite quickly into a new stage of ageing.

That is interesting because it lines up with growing evidence that ageing may happen in waves rather than as one long gradual process.

• Most powerful drug of all is movement, researchers say
• New hybrid therapy aims to remove cancer’s sugar camouflage
• TikTok removes AI weight loss ads from fake Boots account

This was a fish study, so it does not tell us that human lifespan can be predicted the same way.

But it does raise an interesting possibility.

As wearables track sleep, movement and daily rhythms more closely, similar patterns may one day help flag early signs of unhealthy ageing in people.

Researchers followed 5,440 adults aged 50 and over for 12 years using data from the English Longitudinal Study of Ageing.

They found that people with both abdominal obesity and low muscle mass were 83% more likely to die than people without either condition.

That combination is often described as sarcopenic obesity.

It matters because it reflects two problems happening at the same time – more harmful fat around the middle and less protective muscle.

The researchers say excess fat may fuel inflammation and metabolic dysfunction, which then helps drive further muscle loss.

That creates a nasty cycle, especially in older age when muscle is already harder to maintain.

One practical point stands out.

Sarcopenic obesity is usually diagnosed with expensive scans or body composition tests, but this study suggests simpler methods may work as an early screen.

In routine practice, waist measurement plus an estimate of lean mass may be enough to flag people at higher risk.

• Berberine shows no clear advantage over placebo for reducing liver and belly fat
• Increased belly fat associated with higher psoriasis risk
• Belly fat can increase women’s risk of chronic pain by 60%

That could make earlier intervention more realistic.

For older adults, that usually means resistance exercise, enough protein, nutritional support and a focus on reducing central fat rather than weight alone.

This does not mean every person with a larger waist is in immediate danger.

The bigger issue is the combination of too much abdominal fat and too little muscle, which seems to be where the real risk sits.

As more people turn to ChatGPT and other AI tools for mental health advice, researchers are starting to test how these systems actually behave in counselling-style conversations.

A Brown University team worked with mental health practitioners and found repeated ethical problems, even when the models were prompted to use recognised psychotherapy approaches such as CBT or DBT.

The study involved seven peer counsellors trained in cognitive behavioural therapy techniques, along with three licensed clinical psychologists who reviewed simulated chat transcripts for ethical violations.

The models tested included versions of GPT, Claude and Llama.

The researchers identified 15 risks across five broad areas.

These included poor contextual understanding, weak therapeutic collaboration, deceptive empathy, unfair discrimination and failures around safety and crisis management.

Some of the problems were obvious and worrying.

The chatbots sometimes reinforced harmful beliefs, handled crisis situations badly and used emotionally convincing language that created the impression of understanding without genuine comprehension.

That matters because mental health is not just another customer service use case.

When a human therapist gets something badly wrong, there are professional standards, regulators and routes for accountability. With AI counsellors, those systems do not really exist yet.

The study does not argue that AI should be shut out of mental health support altogether.

• Large study tests how AI large language models handle health misinformation
• Wireless retinal implant helps blind patients see again
• Phone use on the toilet may raise risk of haemorrhoids

The authors explicitly note there may be useful roles for AI, especially where access to care is poor. But they also argue that much stronger ethical, legal and educational standards are needed before these systems can be trusted in high stakes settings.

That is the sensible position.

A chatbot may feel supportive, but sounding caring is not the same as being clinically safe.

A large study from Sweden suggests GLP-1 drugs may have mental health benefits as well as metabolic ones.

Researchers looked at national health data from almost 100,000 people between 2009 and 2022.

More than 20,000 of them had used a GLP-1 medicine, including semaglutide.

The researchers found that periods of semaglutide use were linked with fewer psychiatric-related hospital visits and less sickness absence.

The effect on some outcomes was striking.

During semaglutide treatment, the risk of depression was 44% lower and the risk of anxiety disorders was 38% lower.

• GLP-1 medicines: side effects, rare risks and what to monitor
• Weight loss surgery outperforms GLP-1 drugs in real-world use

Substance use related hospital care and sickness absence were also 47% lower during treatment periods.

The study also found a reduced risk of suicidal behaviour among people taking GLP-1 receptor agonists.

That is a notable finding, especially given the debate around whether these drugs might worsen mental health in some people.

There are a few possible explanations.

Some of the benefit may come from weight loss, better blood sugar control, lower alcohol intake or improvements in body image.

The researchers also suggest there may be direct effects on the brain’s reward system.

That is plausible, but it is still only a theory at this stage.

• What happens when patients stop taking GLP-1 drugs
• Most weight lost on GLP-1 drugs returns within a year after stopping

This was a register study, not a randomised trial.

So it shows an association, not proof that the drugs themselves caused the mental health improvements.

Even so, it adds to growing evidence that GLP-1 medicines may do more than lower weight and blood sugar.

For people living with obesity or type 2 diabetes, that broader impact could matter a great deal.

Researchers have identified a region in the brainstem that may play a direct role in high blood pressure.

The area is called the lateral parafacial region.

It normally helps control forced exhalation, such as during coughing, laughing or exercise.

The team found that this same region is also linked to nerves that constrict blood vessels.

That matters because tighter blood vessels can push blood pressure up.

In experiments, the region appeared to be more active in high blood pressure.

When researchers switched it off, blood pressure dropped back towards normal.

That suggests the area may be more than a bystander.

It may be one of the systems actively helping to drive hypertension.

The researchers also traced signals coming from the carotid bodies in the neck.

These small structures help monitor oxygen levels in the blood.

Because the carotid bodies can potentially be targeted without using drugs that affect the whole brain, they may offer a safer treatment route.

• Genetic link between type 2 diabetes and high blood pressure uncovered
• High blood pressure can trigger kidney alterations
• Bedtime blood pressure medication more effective than morning dose

That is especially interesting for people with sleep apnoea, where abnormal breathing and blood pressure often go hand in hand.

Still, this is not a ready-made treatment.

It is a mechanistic finding that helps explain one possible cause of hypertension in some cases.

The bigger point is that high blood pressure is not always just about salt, weight or blood vessels themselves.

In some people, the brain may be playing a bigger part than previously thought.

PFAS are man-made chemicals found in water, food packaging and many everyday products.

They are often called forever chemicals because they do not break down easily and can build up in the body.

A new study suggests that may matter for bone health.

Researchers followed 218 children from a long-running birth cohort and measured PFAS exposure at several stages of childhood.

Bone density was then assessed when the children reached age 12.

Higher levels of one PFAS chemical, PFOA, were linked with lower bone density in the forearm.

For other PFAS compounds, the pattern was less simple.

The link with bone density seemed to depend on when exposure happened.

That suggests some stages of childhood development may be more sensitive than others.

The associations were also stronger in girls than in boys.

That does not mean PFAS definitely cause weaker bones.

This was an observational study, so it cannot prove cause and effect.

• PFAS exposure may blunt blood sugar gains after bariatric surgery in teenagers
• Teenage weight gain after bariatric surgery triggered by elevated blood levels of PFAS
• PFAS: hormone-altering chemicals could be linked to certain cancers in women

But it adds to a growing body of evidence that early exposure to these chemicals may affect long term health in ways that are easy to miss at first.

Bone mass built during adolescence matters for life.

If bone development is impaired early on, the risk of fractures and osteoporosis later may be higher.

The findings also reinforce a broader point.

Reducing contamination in drinking water and consumer products is not just an environmental issue.

It may also be a child health issue.

A new study followed more than 7,200 children in Sweden who started obesity treatment between the ages of 7 and 17.

Researchers tracked them through to age 30.

They compared children with metabolically healthy obesity, children with obesity and abnormal cardiometabolic markers and peers from the general population.

The results were clear.

Even children whose blood pressure and blood tests looked normal still had a much higher risk of later disease than children without obesity.

By age 30, 9% of the metabolically healthy obesity group had developed type 2 diabetes.

That compared with 17% in the metabolically unhealthy group and just 0.5% in the general population.

High blood pressure and abnormal blood lipids followed a similar pattern.

In other words, normal test results in childhood did not mean low risk.

That matters because there has been debate about whether children with obesity but no obvious metabolic complications really need treatment.

• Parent stress may be quietly driving childhood obesity
• Obesity linked to 1 in 10 infection deaths worldwide
• Microbes living in our mouths could hold the key to obesity prevention

This study suggests they do.

All children in the study received support for healthier lifestyle habits.

Those who responded well to treatment had a lower risk of future illness, regardless of whether they were classed as metabolically healthy or unhealthy at the start.

That is the key point.

If a child has obesity, normal blood results should not be used as an excuse to do nothing.

The risk is still there, and early treatment appears to make a difference.

Doctors have long known that physical activity improves health, but it is still not prescribed as often or as seriously as it should be.

Researchers from Wits University argue that movement should be treated as a core part of prevention, treatment and recovery.

Their message is blunt.

When people stop moving, physical decline starts quickly.

Even a single day of inactivity can lead to measurable changes in the cardiovascular and musculoskeletal systems.

On the other hand, physical activity affects metabolism, immunity, recovery and mental wellbeing.

That starts with simple things.

Standing up more often, walking, stretching and breaking up sitting time all have value.

• Keeping Active with Diabetes

The researchers highlight evidence that standing desks can improve posture, reduce back pain and help focus.

Walking programmes were also linked to better heart health and mood.

Exercise before surgery and after illness also appears to improve recovery and reduce complications.

That is important because prehabilitation and rehabilitation still do not get enough attention outside specialist settings.

The researchers also push back against the idea that health only improves once people hit some magic number of steps.

You do not need 10,000 steps a day to start seeing benefit.

• Weight loss injection adverts from CheqUp, MedExpress and WLO pulled after regulator steps in
• Forget 10,000 steps: for older women, 4,000 is enough
• 5 steps to improve your cardiovascular health

Small changes still matter, especially for people starting from a low baseline.

None of this is revolutionary.

The problem is not that the science is unclear.

The problem is that modern life makes movement easy to avoid and healthcare systems still tend to reach for pills before they reach for physical activity advice.

The bottom line is simple.

Movement is not a bonus extra for healthy people.

Obesity is usually discussed in terms of diabetes and heart disease.

Bone health tends to get much less attention.

But obesity can disrupt bone metabolism, weaken bone quality and slow fracture healing.

Researchers studying mice on a high fat diet looked at whether activating a pathway called HIF signalling could help.

This pathway helps cells respond to low oxygen conditions and also affects metabolism, blood vessel formation and tissue repair.

The team used a drug called Roxadustat, which is already approved for some forms of anaemia.

The treated mice gained less weight and built up less body fat, even though they stayed on the same high fat diet.

They also showed better glucose tolerance.

That suggests the treatment improved the way the body handled energy and blood sugar.

The bone findings were just as interesting.

The treated mice had less fat build-up in bone marrow and better preservation of the blood vessel network that supports healthy bone.

They also healed fractures better than untreated obese mice.

That matters because obesity and impaired glucose control can both make fracture repair slower and less reliable.

So the idea of one treatment helping both metabolism and bone is appealing.

• Study highlights how male and female muscle metabolism differ
• Intermittent fasting and HIIT workouts improve metabolism in postmenopausal women
• Gut inflammation: Blastocystis ST7 metabolism can trigger gut disease

But this is still very early stage work.

Mouse studies are useful for understanding mechanisms, but many promising results do not translate into humans.

So this is not a treatment story yet.

It is a proof-of-concept study that points to a pathway worth exploring further.

The Mediterranean diet has long been linked with lower risk of heart disease, diabetes and cognitive decline.

A new study suggests one reason may lie in the mitochondria.

Researchers found that older adults who followed a Mediterranean-style diet more closely had higher levels of two mitochondrial microproteins, humanin and SHMOOSE.

These molecules have attracted interest because they may help protect against oxidative stress, cardiovascular disease and neurodegeneration.

People with higher adherence to the diet also had lower markers of oxidative stress.

Some foods seemed to matter more than others.

• Mediterranean-style diet paired with moderate exercise significantly reduces type 2 diabetes risk
• Mediterranean diet could reduce dementia risk even in those with greater genetic disposition

Olive oil, fish and legumes were linked with higher humanin levels.

Olive oil and lower intake of refined carbohydrates were linked with higher SHMOOSE levels.

That adds a possible new biological explanation for why the Mediterranean diet keeps showing up in healthy ageing research.

Still, this was a small observational study.

It cannot prove that the diet itself caused the higher microprotein levels.

It also cannot tell us whether changing diet will definitely raise these markers or reduce disease risk.

So the findings need to be kept in proportion.

• Mediterranean-style eating linked to lower stroke risk in women
• Vegan diet with unhealthy plant foods still beats Mediterranean diet for weight loss

This is not a breakthrough that changes dietary advice overnight.

What it does do is offer another plausible mechanism for a pattern we have seen for years.

People who eat in a more Mediterranean way tend to do better across a range of health outcomes.

This study suggests mitochondria may be part of that story.

Researchers analysed blood samples from 958 participants in the COSMOS trial to see whether a daily multivitamin changed measures of biological ageing.

The participants were older adults with an average chronological age of around 70. They were followed for two years.

Compared with placebo, daily multivitamin supplementation modestly slowed the rate of ageing on two of the five epigenetic clocks studied, PCGrimAge and PCPhenoAge.

Cocoa extract did not show an effect on any of the five clocks.

The researchers said the overall difference worked out to roughly four months less biological ageing over two years. Benefits were greater in those who started out with accelerated biological ageing.

That sounds good, but the effect was not large.

Independent experts have already pointed out that the change was modest, not seen across all markers and does not yet prove a meaningful real world health benefit on its own.

So this is not evidence that a multivitamin will suddenly make people biologically younger in any dramatic sense.

It is better read as a small signal that nutritional adequacy may influence ageing biology in some older adults.

• Vitamin D3 may halve the risk of a second heart attack
• Vitamin D2 may impair the more efficient virus-busting vitamin D3
• Impact of B vitamins on health and disease revealed in new research

The study also cannot tell us that everyone should start taking a multivitamin.

It does not replace the basics, such as diet quality, physical activity, sleep and not smoking. Still, it is a worthwhile finding.

A Yale-led study using data from more than 11,000 older adults found that ageing is more changeable than many people assume.

Over up to 12 years of follow-up, 45% of participants improved in cognitive function, physical function or both.

Around 32% improved cognitively and 28% improved physically.

The researchers measured cognition using a global performance assessment and physical function using walking speed.

That matters because walking speed is not a trivial measure.

In geriatric medicine, it is often treated as a meaningful indicator of function, frailty and future health risk.

The most interesting part of the study was not just that improvement happened, but what predicted it.

Participants with more positive beliefs about ageing were significantly more likely to improve in both cognition and walking speed, even after adjusting for factors such as age, sex, education, chronic disease, depression and length of follow-up.

In other words, mindset was not everything, but it was not irrelevant either.

The findings fit with earlier work suggesting that negative beliefs about ageing can become internalised and affect health over time.

• Regular aerobic exercise may slow brain ageing in midlife
• Dark chocolate ingredient linked with slower biological ageing
• Live to 100: 5 habits linked with healthier ageing

This does not mean people can simply think their way out of illness or disability.

But it does suggest that later life is not always a steady slide, and that the way ageing is framed by society, clinicians and older adults themselves may shape what happens next.

Researchers from King’s College London reviewed 35 studies involving 52,584 participants with an average age of 17.

They found a consistent association between problematic smartphone use and greater eating disorder symptom severity in non-clinical samples, meaning people without a formal eating disorder diagnosis.

Higher smartphone use was also linked to body dissatisfaction, food addiction symptoms, uncontrolled eating and emotional overeating.

The association appeared strongest in those using their phones for more than seven hours a day.

This matters because adolescence is a period when body image, identity and self-esteem are still taking shape.

Constant exposure to idealised images, comparison culture and appearance-focused content may make some young people more vulnerable to dissatisfaction with their own bodies.

That said, the study has limits.

Most of the evidence was cross-sectional, which means it shows an association rather than proof that phone use causes the problem. The authors rated much of the evidence as low certainty for that reason.

It also mainly applies to non-clinical groups.

The review does not tell us enough yet about young people who already have a diagnosed eating disorder.

• Seasonal Affective Disorder
• Increase in post-pandemic gut-brain disorders revealed in new research
• 1 in 5 males could have an eating disorder

Still, the signal is hard to ignore.

If a young person is spending a large chunk of the day on their phone and showing signs of body dissatisfaction, emotional overeating or loss of control around food, that combination deserves attention.

This is not a case for panic, but it is a case for earlier intervention.

Limiting harmful exposure, improving digital habits and picking up early warning signs may matter just as much as talking about diet alone.

A new Cleveland Clinic study looked at what happened after nearly 8,000 patients stopped injectable semaglutide or tirzepatide in routine clinical practice.

The study included adults with overweight or obesity who had started one of these medicines for obesity or type 2 diabetes, then stopped within three to 12 months.

On average, people treated for obesity lost 8.4% of body weight before stopping, then regained 0.5% over the following year.

People treated for type 2 diabetes lost 4.4% before stopping, then lost a further 1.3% over the next year.

That sounds reassuring, but it needs context.

A substantial number of patients did not simply stop and walk away.

Around 19.6% restarted their original medication, while 35.2% received another obesity treatment within a year.

That included 27.4% who switched to another medicine, 13.7% who had lifestyle modification visits and 0.6% who moved on to metabolic or bariatric surgery.

There was also a lot of individual variation.

In the obesity group, 55% gained weight after stopping, while 45% either kept losing weight or stayed the same.

In the diabetes group, 44% gained weight and 56% stayed the same or kept losing.

So this is not really a story about people stopping treatment and being fine.

It is more a story about people adapting, restarting, switching therapies or continuing with other support.

That may explain why the average regain was smaller than in randomised trials.

• GLP-1 weight loss drugs linked to small rise in chronic cough
• Most weight lost on GLP-1 drugs returns within a year after stopping
• Weight loss surgery outperforms GLP-1 drugs in real-world use

The authors also note that cost, insurance limits and side effects are major reasons people stop in the first place, with cost and coverage being the main issue.